Charles River Laboratories

Charles River Laboratories

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$982,732
$1,004,078
$995,830
$994,227
Gross Profit
357,870
363,374
279,319
307,855
EBITDA
270,484
150,800
63,951
-192,047
EBIT
198,224
83,510
-3,200
-270,324
Net Income
333,067
-1,482
-14,843
-276,555
Net Change In Cash
982,732
1,004,078
995,830
994,227
Free Cash Flow
207,275
148,620
-14,831
58,570
Cash
200,381
192,025
191,830
213,770
Basic Shares
48,584
48,486
48,951
49,216

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$4,015,382
$4,049,989
$4,129,409
$3,976,060
Gross Profit
1,225,573
1,331,821
1,502,556
1,462,651
EBITDA
410,838
581,143
1,032,118
986,148
EBIT
7,526
219,402
717,994
682,278
Net Income
-144,338
10,297
474,624
486,226
Net Change In Cash
4,015,382
4,049,989
4,129,409
3,976,060
Cost of Revenue
-30,679
Free Cash Flow
518,494
501,610
365,370
294,907
Cash
213,770
194,606
276,771
233,912
Basic Shares
49,564
51,628
51,451
51,301

Earnings Calls

QuarterEPS
2026-09-30
$3.09
2026-06-30
$3.02
2026-03-31
$2.06
2025-12-31
$2.39